[go: up one dir, main page]

TW201907011A - Method for producing galactose oligosaccharide - Google Patents

Method for producing galactose oligosaccharide Download PDF

Info

Publication number
TW201907011A
TW201907011A TW107122438A TW107122438A TW201907011A TW 201907011 A TW201907011 A TW 201907011A TW 107122438 A TW107122438 A TW 107122438A TW 107122438 A TW107122438 A TW 107122438A TW 201907011 A TW201907011 A TW 201907011A
Authority
TW
Taiwan
Prior art keywords
galactosidase
reaction
oligosaccharides
amount
concentration
Prior art date
Application number
TW107122438A
Other languages
Chinese (zh)
Other versions
TWI784019B (en
Inventor
池田雅和
伊藤雅彦
Original Assignee
日商養樂多本社股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商養樂多本社股份有限公司 filed Critical 日商養樂多本社股份有限公司
Publication of TW201907011A publication Critical patent/TW201907011A/en
Application granted granted Critical
Publication of TWI784019B publication Critical patent/TWI784019B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/12Disaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/14Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

本發明係提供一種根據半乳糖寡糖的製造方法,來提升三醣以上之半乳糖寡糖的生成量及反應速度的方法,其中該半乳糖寡糖的製造方法,其特徵為在5~60mM之鈉離子及0.5~8mM之鎂離子的存在下,使β-半乳糖苷酶與基質反應。The present invention provides a method for increasing the amount of galacto-oligosaccharides and the reaction speed according to a method for producing galactooligosaccharides. The method for producing galacto-oligosaccharides is characterized in that it is 5 to 60 mM. In the presence of sodium ions and 0.5 to 8 mM magnesium ions, β-galactosidase reacts with the substrate.

Description

半乳糖寡糖的製造方法Method for producing galactooligosaccharide

本發明係有關於一種使用β-半乳糖苷酶之半乳糖寡糖的製造方法,更詳而言之,係有關於一種藉由使β-半乳糖苷酶,在既定濃度之特定的金屬離子的共存下作用於基質,來提升三醣以上之半乳糖寡糖的生成量及反應速度的方法。The present invention relates to a method for producing a galactostooligosaccharide using β-galactosidase, and more particularly, it relates to a specific metal ion at a predetermined concentration by using β-galactosidase. A method for increasing the amount of galacto-oligosaccharides produced by trisaccharide or more and the reaction speed by acting on the matrix under the coexistence of

周知β-半乳糖苷酶可催化將乳糖等之β-D-半乳糖苷鍵水解之反應,以及半乳糖苷基轉移反應,而使用於在腸內選擇性地使雙叉乳酸桿菌增殖之半乳糖寡糖的製造。It is well known that β-galactosidase can catalyze the hydrolysis of β-D-galactosyl bonds such as lactose and the galactosyl transfer reaction, and is used for the selective proliferation of bifidobacterium lactobacillus Manufacture of Lactose Oligosaccharides.

在使用此種β-半乳糖苷酶的反應中,有人探討使半乳糖苷基的轉移率提升的方法。例如,有人提出一種藉由提高基質的乳糖濃度並使β-半乳糖苷酶與其作用來提高轉移率的方法(專利文獻1)。In the reaction using such a β-galactosidase, a method for improving the rate of galactosyl group transfer has been investigated. For example, a method has been proposed in which the transfer rate is increased by increasing the lactose concentration of the substrate and allowing β-galactosidase to react therewith (Patent Document 1).

使用β-半乳糖苷酶之半乳糖苷基轉移反應所產生的生成物,除β-D-半乳哌喃基(1-4)β-D-半乳哌喃基-D葡萄糖(4´-GL)等三醣以上之半乳糖寡糖外,還可能包含例如β-D-半乳哌喃基(1-6)-D-葡萄糖等轉醣苷化雙醣;而由提升雙叉乳酸桿菌增殖促進效果等觀點,而要求進一步提高三醣以上之半乳糖寡糖的生成量之技術。又,基於降低製造成本及改善生產效率之觀點,重要的是縮短三醣以上之半乳糖寡糖的生成量達最大前的反應時間,而企求使反應速度提升的方法。 [先前技術文獻] [專利文獻]Using the product produced by the galactosyl transfer reaction of β-galactosidase, except β-D-galactopyranosyl (1-4) β-D-galactopyranosyl-D glucose (4´ -GL) and other galacto-oligosaccharides, may also contain transglycosidated disaccharides such as β-D-galactopyryl (1-6) -D-glucose; From the viewpoint of the effect of promoting proliferation, etc., a technique for further increasing the amount of galactose oligosaccharides having a trisaccharide or more is required. From the viewpoints of reducing manufacturing costs and improving production efficiency, it is important to shorten the reaction time before the amount of galactose oligosaccharides with a trisaccharide or more is reached, and to increase the reaction speed. [Prior Art Literature] [Patent Literature]

[專利文獻1]日本特公平5-22517號公報[Patent Document 1] Japanese Patent Publication No. 5-22517

[發明所欲解決之課題][Problems to be Solved by the Invention]

本發明之課題在於提供一種在使用β-半乳糖苷酶之半乳糖寡糖的製造方法中,使三醣以上之半乳糖寡糖的生成量及反應速度提升的方法。 [解決課題之手段]An object of the present invention is to provide a method for increasing the amount of galacto-oligosaccharides produced by a trisaccharide or more and the reaction rate in a method for producing a galacto-oligosaccharide using β-galactosidase. [Means for solving problems]

本案發明人等為解決上述課題而致力進行研究的結果發現,藉由在特定濃度範圍之鈉離子及鎂離子的存在下,使β-半乳糖苷酶與基質反應,可增大三醣以上之半乳糖寡糖的生成量,而且可縮短生成量達最大前的反應時間,而完成本發明。As a result of intensive studies conducted by the present inventors to solve the above-mentioned problems, it has been found that by reacting β-galactosidase with a substrate in the presence of sodium ions and magnesium ions in a specific concentration range, it is possible to increase The amount of galactose oligosaccharides produced and the reaction time before the amount of production reaches the maximum can be shortened to complete the present invention.

亦即,本發明為一種半乳糖寡糖的製造方法,其特徵為在5~60mM之鈉離子及0.5~8mM之鎂離子的存在下,使β-半乳糖苷酶與基質反應。 [發明之效果]That is, the present invention is a method for producing galactooligosaccharides, which is characterized in that β-galactosidase and a substrate are reacted in the presence of 5 to 60 mM sodium ions and 0.5 to 8 mM magnesium ions. [Effect of the invention]

根據本發明之製造方法,可提高三醣以上之半乳糖寡糖的生成量,且可提升反應速度,而能夠縮短達到最大生成量前的反應時間。因此,能以低成本效率良好地生產三醣以上之半乳糖寡糖。According to the manufacturing method of the present invention, the amount of galactose oligosaccharides that are more than trisaccharides can be increased, the reaction speed can be increased, and the reaction time before reaching the maximum amount can be shortened. Therefore, it is possible to efficiently produce galacto-oligosaccharides with trisaccharides or more at low cost.

[實施發明之形態][Form of Implementing Invention]

本發明之半乳糖寡糖的製造方法,其特徵為在5~60mM之鈉離子及0.5~8mM之鎂離子的存在下,使β-半乳糖苷酶與基質反應。半乳糖寡糖係包含通式Gal-(Gal)n-Glc(Gal表示半乳糖殘基,Glc表示葡萄糖,n表示1~6之整數)所示之三醣以上之半乳糖寡糖。The method for producing a galacto-oligosaccharide according to the present invention is characterized in that β-galactosidase and a substrate are reacted in the presence of 5 to 60 mM sodium ions and 0.5 to 8 mM magnesium ions. Galacto-oligosaccharides are galacto-oligosaccharides of three or more sugars represented by the general formula Gal- (Gal) n-Glc (Gal represents galactose residues, Glc represents glucose, and n represents an integer of 1 to 6).

β-半乳糖苷酶為用來催化將乳糖或o-硝基苯基-β-D-半乳哌喃糖苷等β-半乳糖苷鍵水解之反應、或半乳糖苷基轉移反應的酵素。就本發明中所使用之β-半乳糖苷酶,不特別限制,基於提升三醣以上之半乳糖寡糖的生成量及反應速度之觀點,較佳為源於屬克魯維酵母(Kluyveromyces)屬、鏈球菌(Streptcoccus)屬、乳桿菌(Lactobacillus)屬、雙叉桿菌(Bifidobacterium)屬或芽孢桿菌(Bacillus)屬等之微生物者,更佳為源於乳酸克魯維酵母(Kluyveromyces lactis)、脆壁克魯維酵母(Kluyveromyces fragilis)、嗜熱鏈球菌(Streptcoccus thermophilus)、保加利亞乳桿菌(Lactobacillus bulgaricus)、短雙叉桿菌(Bifidobacterium breve)者,特佳為源於屬克魯維酵母屬之微生物的β-半乳糖苷酶,再更佳為源於乳酸克魯維酵母之β-半乳糖苷酶。β-galactosidase is an enzyme used to catalyze a hydrolysis reaction of β-galactosyl bonds such as lactose or o-nitrophenyl-β-D-galactopyranoside, or a galactosyl transfer reaction. The β-galactosidase used in the present invention is not particularly limited. From the viewpoint of increasing the amount of galacto-oligosaccharides and the reaction rate of trisaccharide or more, it is preferably derived from Kluyveromyces Microbes of the genus, Streptcoccus, Lacobacillus, Bifidobacterium, or Bacillus, and more preferably derived from Kluyveromyces lactis, Kluyveromyces fragilis, Streptcoccus thermophilus, Lactobacillus bulgaricus, Bifidobacterium breve, especially from the genus Kluyveromyces The β-galactosidase of microorganisms is even more preferably β-galactosidase derived from Kluyveromyces lactis.

作為上述β-半乳糖苷酶之市售品,可舉出例如源於乳酸克魯維酵母(Kluyveromyces lactis)之GODO-YNL(合同酒精股份有限公司製)、Maxilact LG5000(DSM公司製)或源於脆壁克魯維酵母(Kluyveromyces fragilis)之Lactozymes 3000L(Novozymes公司製)、源於嗜熱鏈球菌(Streptcoccus thermophilus)之Lactase Y-ST(Yakult Pharmaceutical Industry股份有限公司製)等。Examples of the commercially available β-galactosidase include GODO-YNL (manufactured by Contract Alcohol Co., Ltd.) derived from Kluyveromyces lactis, Maxilact LG5000 (manufactured by DSM), or a source thereof. Lactozymes 3000L (manufactured by Novozymes) of Kluyveromyces fragilis, Lactase Y-ST (manufactured by Yakult Pharmaceutical Industry Co., Ltd.) derived from Streptcoccus thermophilus, and the like.

具有β-半乳糖苷酶活性之微生物或源於該微生物之β-半乳糖苷酶的形態不特別限定,可舉出例如培養液、將培養液經離心分離或膜處理等濃縮而成的菌體濃縮液或顆粒、乾燥菌體、菌體碎屑、粗酵素溶液、純化酵素溶液、酵素粉末等,此等可依循周知方法來調製。The form of a microorganism having a β-galactosidase activity or a β-galactosidase derived from the microorganism is not particularly limited, and examples thereof include a culture solution, a strain obtained by concentrating the culture solution by centrifugation, or membrane treatment. Body concentrates or granules, dried cells, cell debris, crude enzyme solution, purified enzyme solution, enzyme powder, etc. can be prepared according to well-known methods.

例如,使用具有β-半乳糖苷酶活性之微生物時,可直接使用依循周知微生物培養方法進行培養而得到的培養液,或者視需求實施周知之離心分離、膜處理、乾燥、粉碎等處理,而以菌體濃縮液或顆粒、乾燥菌體、菌體碎屑液等使用。菌體可為活菌體狀態,亦可實施有機溶劑處理、冷凍乾燥處理等使菌體死亡。For example, when using microorganisms with β-galactosidase activity, a culture liquid obtained by culturing according to a known microorganism culture method may be directly used, or a known centrifugation, membrane treatment, drying, and pulverization treatment may be performed as required, and Used as bacterial cell concentrate or granules, dried bacterial cells, bacterial cell debris liquid, etc. The bacterial cells may be in a state of living bacterial cells, or they may be subjected to an organic solvent treatment, a freeze-drying treatment, or the like to cause the bacterial cells to die.

此外,使用源於具有β-半乳糖苷酶活性之微生物的β-半乳糖苷酶時,純化條件、純化度無特別限制,可使用一般的純化手法。依循周知方法將該微生物進行培養後,以離心分離、膜處理等分離手段將菌體分離,若培養上清液中含有β-半乳糖苷酶時可將其回收,而形成粗酵素溶液。又,若菌體內含有β-半乳糖苷酶時,可藉由均質機或超音波處理將菌體以物理方式粉碎,或透過使用細胞壁溶解酵素等以酵素方式進行處理,得到菌體內萃取液,而形成粗酵素溶液。亦可對此等粗酵素溶液,適宜組合硫酸銨鹽析處理、透析、凝膠過濾層析法、離子交換層析法、吸附層析法、親和層析法等,而形成高純化度的純化酵素溶液。In addition, when β-galactosidase derived from a microorganism having β-galactosidase activity is used, the purification conditions and degree of purification are not particularly limited, and general purification methods can be used. After the microorganism is cultured according to a well-known method, the cells are separated by separation means such as centrifugation and membrane treatment. If the culture supernatant contains β-galactosidase, it can be recovered to form a crude enzyme solution. In addition, if β-galactosidase is contained in the bacteria, the bacteria can be physically pulverized by a homogenizer or ultrasonic treatment, or treated in an enzyme manner by using a cell wall to dissolve an enzyme, etc. A crude enzyme solution is formed. These crude enzyme solutions can also be combined with ammonium sulfate salting-out treatment, dialysis, gel filtration chromatography, ion exchange chromatography, adsorption chromatography, affinity chromatography, etc. to form a highly purified purification. Enzyme solution.

就與上述β-半乳糖苷酶作用之基質而言,係包含以下兩種情形:發揮作為半乳糖苷基之受體及供體之作用的單獨基質、與半乳糖苷基之受體與供體分別共存者。作為半乳糖苷基之供體的基質,可舉出乳糖、o-硝基苯基-β-D-半乳哌喃糖苷等。又,作為半乳糖苷基之受體的基質,可舉出乳糖、半乳糖寡糖、葡萄糖、甘油等。The matrix that interacts with the above-mentioned β-galactosidase includes the following two cases: a separate matrix that functions as a galactosyl acceptor and donor, and a galactosyl acceptor and donor Coexistence. Examples of the matrix of the galactosyl group donor include lactose, o-nitrophenyl-β-D-galactopyranoside, and the like. Examples of the matrix of the galactosyl receptor include lactose, galactooligosaccharide, glucose, and glycerol.

基質的濃度係依據其種類等適宜設定,例如使用乳糖時,由提升三醣以上之半乳糖寡糖的生成量及生成速度之效果而言,其濃度較佳為5~65質量%,更佳為15~60質量%。又,β-半乳糖苷酶的添加量可配合所要之反應時間適宜調整,按乳糖每1g較佳為10~1000U,更佳為30~800U。反應溫度等可依據使用之β-半乳糖苷酶的最佳溫度等適宜設定。例如,使用源於乳酸克魯維酵母的β-半乳糖苷酶時,反應溫度較佳為30~50℃,更佳為40~50℃。此外,酵素活性(U)的測定如下: [β-半乳糖苷酶酵素活性(U)的測定法]   將稀釋酵素試料0.5mL取至試管中,添加含氯化錳之100mM的KH2 PO4 -NaOH緩衝液(pH6.5,下稱「緩衝液」) 0.5mL並加以混合而使其成為0.1mM後,於37℃保溫3分鐘。添加預先於37℃保溫的0.1%之o-硝基苯基-β-D-半乳哌喃糖苷(下稱「ONPG」)溶液1.0mL並迅速加以混合,正確地於37℃保溫1分鐘。添加0.2M的碳酸鈉溶液2.0mL並迅速加以混合,而將反應停止(試驗系)。另外將稀釋酵素試料0.5mL取至試管中,添加緩衝液0.5mL並加以混合後,添加0.2M的碳酸鈉溶液2.0mL,於37℃保溫3分鐘,添加預先於37℃保溫的ONPG溶液0.1mL並加以混合,正確地於37℃保溫1分鐘(盲檢系)。以蒸餾水作為對照組測定試驗系及盲檢系之420nm的吸光度,根據下式算出酵素活性(U)。 [算式1]   酵素活性 =(A1 -A2 )×10×B   A1 :試驗系的吸光度   A2 :盲檢系的吸光度   B:稀釋倍率   *U/mlThe concentration of the substrate is appropriately set according to the type and the like. For example, when lactose is used, the concentration of the galacto-oligosaccharide and the production rate of the trisaccharide and the like are preferably 5 to 65% by mass, more preferably. It is 15 to 60 mass%. In addition, the addition amount of β-galactosidase can be appropriately adjusted according to the required reaction time, and it is preferably 10 to 1000 U, more preferably 30 to 800 U per 1 g of lactose. The reaction temperature and the like can be appropriately set depending on the optimum temperature of the β-galactosidase used and the like. For example, when β-galactosidase derived from Kluyveromyces lactis is used, the reaction temperature is preferably 30 to 50 ° C, and more preferably 40 to 50 ° C. In addition, the measurement of enzyme activity (U) was as follows: [Measurement method of β-galactosidase enzyme activity (U)] 0.5 mL of a diluted enzyme sample was taken into a test tube, and 100 mM KH 2 PO 4 containing manganese chloride was added. -NaOH buffer solution (pH 6.5, hereinafter referred to as "buffer") 0.5 mL, mixed to make 0.1 mM, and then incubated at 37 ° C for 3 minutes. 1.0 mL of a 0.1% solution of o-nitrophenyl-β-D-galactopyranoside (hereinafter referred to as "ONPG"), which was previously incubated at 37 ° C, was added and quickly mixed, and the temperature was accurately maintained at 37 ° C for 1 minute. The reaction was stopped by adding 2.0 mL of a 0.2 M sodium carbonate solution and rapidly mixing the mixture. In addition, 0.5 mL of the diluted enzyme sample was taken into a test tube, and 0.5 mL of a buffer solution was added and mixed. Then, 2.0 mL of a 0.2 M sodium carbonate solution was added, and the mixture was incubated at 37 ° C for 3 minutes. Then, 0.1 mL of an ONPG solution which was previously maintained at 37 ° C was added. They were mixed and kept at 37 ° C for 1 minute (blind inspection system). The absorbance at 420 nm of the test system and the blind test system was measured using distilled water as a control group, and the enzyme activity (U) was calculated according to the following formula. [Equation 1] Enzyme activity * = (A 1 -A 2 ) × 10 × B A 1 : absorbance of test system A 2 : absorbance of blind test system B: dilution ratio * U / ml

於本發明中,係使上述β-半乳糖苷酶在鈉離子及鎂離子的存在下與基質反應。反應系統中之鈉離子的濃度為5~60mM。另一方面,鎂離子的濃度為0.5~8mM,更佳為1.5~8mM。當鈉離子濃度大於60mM或鎂離子濃度大於8mM時,將所得半乳糖寡糖進行脫鹽而純化時的負擔會變大而不佳。藉由使鈉離子及鎂離子以此種範圍共存,可提升三醣以上之半乳糖寡糖的生成量及反應速度。就鈉離子及鎂離子,可將氯化物、碳酸鹽、乙酸鹽、磷酸鹽等鹽以固體或緩衝液之形態添加於反應系統,而由添加後pH較不易變化而言,較佳為氯化鈉及氯化鎂。In the present invention, the β-galactosidase is reacted with a substrate in the presence of sodium ions and magnesium ions. The concentration of sodium ions in the reaction system is 5 to 60 mM. On the other hand, the concentration of magnesium ions is 0.5 to 8 mM, and more preferably 1.5 to 8 mM. When the sodium ion concentration is more than 60 mM or the magnesium ion concentration is more than 8 mM, the burden on desalting and purifying the obtained galactooligosaccharide becomes large and unfavorable. The coexistence of sodium ions and magnesium ions in this range can increase the amount of galactose oligosaccharides and the reaction speed of trisaccharides or more. For sodium and magnesium ions, salts such as chlorides, carbonates, acetates, and phosphates can be added to the reaction system in the form of solids or buffers. Since the pH is less likely to change after the addition, chlorination is preferred. Sodium and magnesium chloride.

一般而言,β-半乳糖苷酶之半乳糖苷基轉移反應係與基質的水解反應彼此競爭,因此,若使β-半乳糖苷酶作用於基質,則會產生所要的半乳糖寡糖,同時也會因相競爭的水解反應而生成葡萄糖或半乳糖等單糖,而且一度生成的半乳糖寡糖也會受到水解。如此,半乳糖苷基轉移反應與水解反應彼此競爭,隨之,半乳糖苷基之供體與受體亦可能生成各種組合,因此,便不易使特定供體與受體間的半乳糖苷基轉移反應優先進行,而不易控制成生成所要的半乳糖寡糖。相對於此,於本發明中,藉由在特定濃度範圍之鈉離子及鎂離子的存在下使β-半乳糖苷酶作用於基質,在半乳糖寡糖中尤其可使三醣以上之半乳糖寡糖的生成量增加,甚而可提高其反應速度而縮短生成量達最大前的到達時間,而能夠以低成本效率良好地生產三醣以上之半乳糖寡糖。Generally speaking, the galactosyl transfer reaction of β-galactosidase competes with the hydrolysis reaction of the substrate. Therefore, if β-galactosidase is applied to the substrate, the desired galactooligosaccharide is produced. At the same time, monosaccharides such as glucose or galactose are also produced due to competing hydrolysis reactions, and galactooligosaccharides that are once produced are also hydrolyzed. In this way, the galactosyl transfer reaction and the hydrolysis reaction compete with each other, and the galactosyl donor and the acceptor may also form various combinations. Therefore, it is not easy to make the galactosyl group between the specific donor and the acceptor. The transfer reaction proceeds preferentially and is not easily controlled to produce the desired galactooligosaccharide. In contrast, in the present invention, by causing β-galactosidase to act on a substrate in the presence of sodium ions and magnesium ions in a specific concentration range, galactose and oligosaccharides in particular can be used in galactose oligosaccharides. Increasing the amount of oligosaccharides produced can even increase the reaction speed and shorten the time to reach the maximum amount of oligosaccharides, and it is possible to produce galactose oligosaccharides with trisaccharides or more efficiently at low cost.

又,本發明之方法亦可適用於根據使2種β-半乳糖苷酶作用之逐次反應之半乳糖寡糖的製造中的二次反應。亦即,作為一次反應,使具有β-半乳糖苷酶活性之微生物或源於該微生物之β-半乳糖苷酶與基質反應後,作為二次反應,使與一次反應所使用者不同的β-半乳糖苷酶,在5~60mM之鈉離子及0.5~8mM之鎂離子的存在下作用於一次反應液,可使未反應之基質減少,同時使半乳糖寡糖的生成量增大。In addition, the method of the present invention is also applicable to a secondary reaction in the production of galactooligosaccharides based on a sequential reaction in which two kinds of β-galactosidases act. That is, as a primary reaction, a microorganism having β-galactosidase activity or a β-galactosidase derived from the microorganism is reacted with the substrate, and a secondary reaction is performed to make β different from the user of the primary reaction. -Galactosidase, which acts on a primary reaction solution in the presence of 5 to 60 mM sodium ions and 0.5 to 8 mM magnesium ions, can reduce unreacted substrates and increase the amount of galacto-oligosaccharides produced.

就一次反應所使用之具有β-半乳糖苷酶活性之微生物而言,較佳為例如屬擲孢酵母菌(Sporobolomyces)屬、麴菌(Aspergillus)屬、芽孢桿菌(Bacillus)屬之微生物,特佳為屬擲孢酵母菌屬之微生物,基於提升三醣以上之半乳糖寡糖的生成量及反應速度之觀點,再更佳為獨特擲孢酵母(Sporobolomyces singularis)。As for the microorganism having β-galactosidase activity used in a single reaction, for example, microorganisms belonging to the genus Sporobolomyces, Aspergillus, and Bacillus, particularly Microorganisms belonging to the genus Trichoderma are preferred. From the standpoint of increasing the amount of galactose oligosaccharides and the reaction speed of trisaccharides or more, Sporobolomyces singularis is even more preferred.

作為一次反應中所使用之具有β-半乳糖苷酶活性之微生物或源於該微生物之β-半乳糖苷酶的形態不特別限定,可舉出例如培養液、將培養液經離心分離或膜處理等濃縮而成的菌體濃縮液或顆粒、乾燥菌體、菌體碎屑、粗酵素溶液、純化酵素溶液、酵素粉末等,此等可依循周知方法來調製。The form of the microorganism having β-galactosidase activity or β-galactosidase derived from the microorganism used in the primary reaction is not particularly limited, and examples thereof include a culture solution, a culture solution subjected to centrifugation, or a membrane Concentrated bacterial cells or granules, dried bacterial cells, bacterial cell debris, crude enzyme solution, purified enzyme solution, enzyme powder, etc., which are concentrated by treatment, can be prepared according to well-known methods.

例如,使用具有β-半乳糖苷酶活性之微生物時,可直接使用依循周知微生物培養方法進行培養而得到的培養液,或者視需求實施周知之離心分離、膜處理、乾燥、粉碎等處理,而以菌體濃縮液或顆粒、乾燥菌體、菌體碎屑液等使用。菌體可為活菌體狀態,亦可實施有機溶劑處理、冷凍乾燥處理等使菌體死亡。For example, when using microorganisms with β-galactosidase activity, a culture liquid obtained by culturing according to a known microorganism culture method may be directly used, or a known centrifugation, membrane treatment, drying, and pulverization treatment may be performed as required, and Used as bacterial cell concentrate or granules, dried bacterial cells, bacterial cell debris liquid, etc. The bacterial cells may be in a state of living bacterial cells, or they may be subjected to an organic solvent treatment, a freeze-drying treatment, or the like to cause the bacterial cells to die.

此外,使用源於具有β-半乳糖苷酶活性之微生物的β-半乳糖苷酶時,純化條件、純化度無特別限制,可使用一般的純化手法。依循周知方法將該微生物進行培養後,以離心分離、膜處理等分離手段將菌體分離,若培養上清液中含有β-半乳糖苷酶時可將其回收,而形成粗酵素溶液。又,若菌體內含有β-半乳糖苷酶時,可藉由均質機或超音波處理將菌體以物理方式粉碎,或透過使用細胞壁溶解酵素等以酵素方式進行處理,得到菌體內萃取液,而形成粗酵素溶液。亦可對此等粗酵素溶液,適宜組合硫酸銨鹽析處理、透析、凝膠過濾層析法、離子交換層析法、吸附層析法、親和層析法等,而形成高純化度的純化酵素溶液。In addition, when β-galactosidase derived from a microorganism having β-galactosidase activity is used, the purification conditions and degree of purification are not particularly limited, and general purification methods can be used. After the microorganism is cultured according to a well-known method, the cells are separated by separation means such as centrifugation and membrane treatment. If the culture supernatant contains β-galactosidase, it can be recovered to form a crude enzyme solution. In addition, if β-galactosidase is contained in the bacteria, the bacteria can be physically pulverized by a homogenizer or ultrasonic treatment, or treated in an enzyme manner by using a cell wall to dissolve an enzyme, etc., to obtain an extract in the bacteria. A crude enzyme solution is formed. These crude enzyme solutions can also be combined with ammonium sulfate salting-out treatment, dialysis, gel filtration chromatography, ion exchange chromatography, adsorption chromatography, affinity chromatography, etc. to form a highly purified purification. Enzyme solution.

於一次反應中,係使上述具有β-半乳糖苷酶活性之微生物或源於該微生物之β-半乳糖苷酶與乳糖等基質反應。反應條件可依據使用之具有β-半乳糖苷酶活性之微生物或源於該微生物之β-半乳糖苷酶的特性適宜設定。例如,使用獨特擲孢酵母作為具有β-半乳糖苷酶活性之微生物,且使用乳糖作為基質時,由提升半乳糖寡糖的生成量及生成速度之效果而言,乳糖的濃度較佳為10~60質量%,更佳為40~50質量%。又,獨特擲孢酵母的添加量,按乳糖每1g較佳為0.03~0.3U,更佳為0.2~0.3U。再者,反應溫度為30~70℃左右,只要使其反應24~96小時左右即可。In one reaction, the microorganism having β-galactosidase activity or β-galactosidase derived from the microorganism is reacted with a substrate such as lactose. The reaction conditions can be appropriately set according to the characteristics of the microorganism having β-galactosidase activity or β-galactosidase derived from the microorganism. For example, when using Trichosporum sp. As a microorganism having β-galactosidase activity and using lactose as a substrate, the concentration of lactose is preferably 10 in terms of the effect of increasing the amount and rate of galactooligosaccharide production. -60 mass%, more preferably 40-50 mass%. In addition, the addition amount of Trichoderma sp. Yeast is preferably 0.03 to 0.3U, more preferably 0.2 to 0.3U per gram of lactose. The reaction temperature is about 30 to 70 ° C, and the reaction can be performed for about 24 to 96 hours.

於二次反應中,係在特定濃度範圍之鈉離子及鎂離子的存在下,使與一次反應所使用者不同的β-半乳糖苷酶作用於一次反應中所得之一次反應液。In the secondary reaction, in the presence of sodium and magnesium ions in a specific concentration range, β-galactosidase, which is different from the user of the primary reaction, acts on the primary reaction solution obtained in the primary reaction.

二次反應中所使用之β-半乳糖苷酶不特別限制,由提升三醣以上之半乳糖寡糖的生成量及反應速度而言,較佳為源於屬克魯維酵母(Kluyveromyces)屬、鏈球菌(Streptcoccus)屬、乳桿菌(Lactobacillus)屬、雙叉桿菌(Bifidobacterium)屬或芽孢桿菌(Bacillus)屬等之微生物者,更佳為源於乳酸克魯維酵母(Kluyveromyces lactis)、脆壁克魯維酵母(Kluyveromyces fragilis)、嗜熱鏈球菌(Streptcoccus thermophilus)、保加利亞乳桿菌(Lactobacillus bulgaricus)、短雙叉桿菌(Bifidobacterium breve)者,特佳為源於屬克魯維酵母屬之微生物的β-半乳糖苷酶,再更佳為源於乳酸克魯維酵母之β-半乳糖苷酶。The β-galactosidase used in the secondary reaction is not particularly limited. From the viewpoint of increasing the amount of galacto-oligosaccharides and the reaction speed of trisaccharide or more, it is preferably derived from the genus Kluyveromyces , Streptcoccus, Lactobacillus, Bifidobacterium, or Bacillus genus, preferably Kluyveromyces lactis, fragile Kluyveromyces fragilis, Streptcoccus thermophilus, Lactobacillus bulgaricus, Bifidobacterium breve, especially from microorganisms belonging to the genus Kluyveromyces Β-galactosidase is even more preferably β-galactosidase derived from Kluyveromyces lactis.

藉由使上述β-半乳糖苷酶在特定濃度範圍之鈉離子及鎂離子的存在下作用於一次反應液,可增加三醣以上之半乳糖寡糖的生成量。而且,亦可提升其反應速度,可縮短三醣以上之半乳糖寡糖的生成量達最大前的反應時間。二次反應液中之鈉離子的濃度為5~60mM。另一方面,鎂離子的濃度為0.5~8mM,更佳為1.5~8mM。當鈉離子濃度大於60mM或鎂離子濃度大於8mM時,將所得半乳糖寡糖進行脫鹽而純化時的負擔會變大而不佳。藉由使鈉離子及鎂離子以此種濃度範圍存在,可提升半乳糖寡糖的生成量及生產效率。就鈉離子及鎂離子,可將氯化物、碳酸鹽、乙酸鹽、磷酸鹽等鹽以固體或緩衝液之形態添加於反應系統,而由添加後pH較不易變化而言,較佳為氯化鈉及氯化鎂。By causing the β-galactosidase to act on the primary reaction solution in the presence of sodium ions and magnesium ions in a specific concentration range, it is possible to increase the amount of galactose oligosaccharides produced by a trisaccharide or more. In addition, the reaction speed can be increased, and the reaction time before the amount of trisaccharide or more galacto-oligosaccharides reaches the maximum can be shortened. The concentration of sodium ions in the secondary reaction solution is 5 to 60 mM. On the other hand, the concentration of magnesium ions is 0.5 to 8 mM, and more preferably 1.5 to 8 mM. When the sodium ion concentration is more than 60 mM or the magnesium ion concentration is more than 8 mM, the burden on desalting and purifying the obtained galactooligosaccharide becomes large and unfavorable. By allowing sodium ions and magnesium ions to exist in this concentration range, the amount of galactose oligosaccharides produced and production efficiency can be improved. For sodium and magnesium ions, salts such as chlorides, carbonates, acetates, and phosphates can be added to the reaction system in the form of solids or buffers. Since the pH is less likely to change after the addition, chlorination is preferred. Sodium and magnesium chloride.

一次反應液中殘留乳糖的濃度,由提升三醣以上之半乳糖寡糖的生成量及反應速度之效果而言,較佳為5~65質量%,更佳為15~60質量%。又,β-半乳糖苷酶的添加量,按殘留乳糖每1g較佳為10~1000U,更佳為30~800U。反應溫度等可依據使用之β-半乳糖苷酶的最佳溫度等適宜設定。例如,使用源於乳酸克魯維酵母之β-半乳糖苷酶時,由提升三醣以上之半乳糖寡糖的生成量及生成速度之效果而言,反應溫度較佳為30~50℃,更佳為40~50℃。The concentration of residual lactose in the primary reaction solution is preferably from 5 to 65% by mass, and more preferably from 15 to 60% by mass, in terms of the effect of increasing the amount of galactose oligosaccharide produced by the trisaccharide or more and the reaction speed. The addition amount of β-galactosidase is preferably 10 to 1000 U, more preferably 30 to 800 U per 1 g of residual lactose. The reaction temperature and the like can be appropriately set depending on the optimum temperature of the β-galactosidase used and the like. For example, when β-galactosidase derived from Kluyveromyces lactis is used, the reaction temperature is preferably from 30 to 50 ° C in terms of the effect of increasing the amount of galactose oligosaccharides and the rate of production, More preferably, it is 40 to 50 ° C.

如以上所述,生成有半乳糖寡糖的反應液可直接或者適宜進行採活性碳之脫色、採矽藻土之過濾、採離子交換樹脂之脫鹽、使用濃縮機之濃縮而製成液糖、或藉由噴霧乾燥機等予以粉末化製成食品素材而利用。例如,亦可直接製成餐用砂糖來利用,或添加於發酵乳、乳酸菌飲料、麵包、果醬或點心類等飲食品。此時的添加濃度不特別限定,只要鑒於其風味或物性等而適宜決定即可。除此類食品以外,亦可利用於化妝品、醫藥品等。As mentioned above, the reaction liquid with galactose oligosaccharide can be directly or suitably decolorized with activated carbon, filtered with diatomaceous earth, desalted with ion exchange resin, concentrated using a concentrator to make liquid sugar, Alternatively, it can be powdered by a spray dryer or the like to be used as a food material. For example, it can also be used directly as sugar for meals, or it can be added to foods such as fermented milk, lactic acid bacteria drinks, bread, jams, and snacks. The added concentration at this time is not particularly limited as long as it is appropriately determined in view of its flavor, physical properties, and the like. In addition to such foods, it can also be used in cosmetics, pharmaceuticals, and the like.

以下舉出實施例對本發明更詳細地加以說明,惟本發明不受此等任何限制。 [實施例]The following examples illustrate the invention in more detail, but the invention is not limited in any way. [Example]

實施例1   在容積100mL的三角燒瓶中秤量15g日本藥典等級之乳糖,添加85g之以去離子水調製(未含鈉離子與鎂離子)的Bis-Tris緩衝液(pH6.8)(乳糖濃度15%)。於沸騰水浴中將乳糖完全溶解後,在45℃的恆溫水槽中冷卻。對其以鈉離子濃度達15mM的方式添加2.6M的氯化鈉,並以鎂離子濃度達下述表1所記載之濃度的方式添加0.75M的氯化鎂,對此等以按乳糖1g為600U的比例添加GODO-YNL(源於乳酸克魯維酵母之β-半乳糖苷酶,合同酒精股份有限公司製),於40℃使其反應。將此等反應液隨時間經過進行取樣至第7小時為止,並於沸騰水浴中升溫至90℃使酵素失活後,藉由根據下述條件的HPLC分析來測定殘留雙糖與三醣以上之半乳糖寡糖的比例。將各鎂離子濃度下之三醣以上之半乳糖寡糖的生成量達最大時的測定結果示於表1。此外,殘留雙糖中係含有未反應之乳糖及轉醣苷化雙醣。Example 1 Weigh 15g of Japanese Pharmacopoeia grade lactose in a 100mL Erlenmeyer flask, and add 85g of Bis-Tris buffer (pH 6.8) (lactose concentration 15) prepared with deionized water (without sodium and magnesium ions). %). After lactose was completely dissolved in a boiling water bath, it was cooled in a constant temperature water tank at 45 ° C. 2.6 M sodium chloride was added so that the sodium ion concentration reached 15 mM, and 0.75 M magnesium chloride was added so that the magnesium ion concentration reached the concentration described in Table 1 below. To this, 600 U of 1 g of lactose was added. GODO-YNL (β-galactosidase derived from Kluyveromyces lactis, manufactured by Contract Alcohol Co., Ltd.) was added in proportions, and reacted at 40 ° C. These reaction solutions were sampled over time until the seventh hour, and the temperature was raised to 90 ° C in a boiling water bath to deactivate the enzyme, and the residual disaccharides and trisaccharides were measured by HPLC analysis under the following conditions. The ratio of galactooligosaccharides. Table 1 shows the measurement results when the amount of galacto-oligosaccharides having a trisaccharide or more at each magnesium ion concentration reached the maximum. In addition, the residual disaccharide contained unreacted lactose and transglycosidated disaccharide.

<HPLC條件>   管柱:Shodex SUGAR KS-802   移動層:純水   流速:0.5mL/min   檢測:差示折射計<HPLC conditions> Column: Shodex SUGAR KS-802 Mobile layer: pure water Flow rate: 0.5mL / min Detection: Differential refractometer

實施例2   除以鈉離子濃度達30mM的方式添加2.6M的氯化鈉係以與實施例1同樣的方式測定殘留雙糖與三醣以上之半乳糖寡糖的比例。將結果示於表2。Example 2 The ratio of a residual disaccharide to a galacto-oligosaccharide with a trisaccharide or more was measured in the same manner as in Example 1 except that 2.6 M sodium chloride was added so that the sodium ion concentration reached 30 mM. The results are shown in Table 2.

實施例3   除將反應液中的乳糖濃度取45%、以鈉離子濃度達5mM的方式添加2.6M的氯化鈉,並以按乳糖1g為250U的比例添加GODO-YNL且於45℃使其反應以外係以與實施例1同樣的方式測定殘留雙糖與三醣以上之半乳糖寡糖的比例。將結果示於表3。Example 3 Depletion The concentration of lactose in the reaction solution was 45%, and 2.6 M sodium chloride was added so that the sodium ion concentration reached 5 mM. GODO-YNL was added at a rate of 250 U to 1 g of lactose, and the temperature was adjusted to 45 ° C. Except for the reaction, the ratio of the residual disaccharide to the galacto-oligosaccharide of trisaccharide or more was measured in the same manner as in Example 1. The results are shown in Table 3.

實施例4   除將反應液中的乳糖濃度取45%、以鈉離子濃度達60mM的方式添加2.6M的氯化鈉,並以按乳糖1g為250U的比例添加GODO-YNL且於45℃使其反應以外係以與實施例1同樣的方式測定殘留雙糖與三醣以上之半乳糖寡糖的比例。將結果示於表4。Example 4 Depletion The concentration of lactose in the reaction solution was 45%, 2.6 M sodium chloride was added so that the sodium ion concentration reached 60 mM, and GODO-YNL was added at a ratio of 250 U to 1 g of lactose, and the temperature was adjusted to 45 ° C. Except for the reaction, the ratio of the residual disaccharide to the galacto-oligosaccharide of trisaccharide or more was measured in the same manner as in Example 1. The results are shown in Table 4.

由表1及表2可知,透過以鈉離子濃度達15mM及30mM、鎂離子達0.5mM以上的方式添加,三醣以上之半乳糖寡糖的生成量達最大前的反應時間,與鎂離子濃度為0mM及0.1mM時相比縮短至一半以下。又,其顯示隨著鎂離子濃度的增加,三醣以上之半乳糖寡糖的生成量亦增加。再者,可知鈉離子濃度為15mM時,藉由添加鎂離子達1.5mM以上,可進一步縮短三醣以上半乳糖寡糖的生成量達最大前的反應時間。又,由表3及表4可知,當鈉離子濃度為5mM、60mM時,藉由添加鎂離子達0.5mM以上,與鎂離子濃度為0mM及0.1mM時相比可縮短三醣以上之半乳糖寡糖的生成量達最大前的反應時間;其顯示隨著鎂離子濃度的增加,尤其是鎂離子濃度為1.5mM以上,三醣以上之半乳糖寡糖的生成量亦增加。 [產業上可利用性]From Tables 1 and 2, it can be seen that by adding sodium ions with a concentration of 15 mM and 30 mM and magnesium ions above 0.5 mM, the reaction time before the amount of galacto-oligosaccharides with a trisaccharide or more reaches the maximum, and the concentration of magnesium ions When it is 0 mM and 0.1 mM, it is shortened to less than half. In addition, it was shown that as the concentration of magnesium ions increases, the amount of galactose oligosaccharides higher than trisaccharides also increases. In addition, it was found that when the sodium ion concentration was 15 mM, the reaction time before the maximum amount of trisaccharide or more galactooligosaccharide was produced could be further shortened by adding magnesium ions to 1.5 mM or more. As can be seen from Tables 3 and 4, when the sodium ion concentration is 5 mM and 60 mM, by adding magnesium ions to 0.5 mM or more, the galactose can be shortened by more than trisaccharides when the magnesium ion concentration is 0 mM and 0.1 mM The reaction time before the amount of oligosaccharide produced reaches the maximum; it shows that as the concentration of magnesium ions increases, especially when the concentration of magnesium ions is above 1.5 mM, the amount of galactose oligosaccharides above the trisaccharide is also increased. [Industrial availability]

根據本發明,由於能以較短的反應時間提高三醣以上之半乳糖寡糖的生成量,而有用於作為工業上的半乳糖寡糖的製造方法。According to the present invention, it is possible to increase the amount of galacto-oligosaccharides produced from trisaccharides or more with a short reaction time, and it is useful as an industrial method for producing galacto-oligosaccharides.

Claims (3)

一種半乳糖寡糖的製造方法,其特徵為在5~60mM之鈉離子及0.5~8mM之鎂離子的存在下,使β-半乳糖苷酶與基質反應。A method for producing galactooligosaccharides, characterized in that β-galactosidase is reacted with a substrate in the presence of 5 to 60 mM sodium ions and 0.5 to 8 mM magnesium ions. 如請求項1之製造方法,其中鎂離子的濃度為1.5~8mM。The method according to claim 1, wherein the concentration of magnesium ions is 1.5 to 8 mM. 如請求項1或2之製造方法,其中β-半乳糖苷酶為源於屬克魯維酵母屬之微生物者。The method according to claim 1 or 2, wherein β-galactosidase is derived from a microorganism belonging to the genus Kluyveromyces.
TW107122438A 2017-07-04 2018-06-29 Method for producing galactooligosaccharides TWI784019B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017-130761 2017-07-04
JP2017130761 2017-07-04

Publications (2)

Publication Number Publication Date
TW201907011A true TW201907011A (en) 2019-02-16
TWI784019B TWI784019B (en) 2022-11-21

Family

ID=64950827

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107122438A TWI784019B (en) 2017-07-04 2018-06-29 Method for producing galactooligosaccharides

Country Status (9)

Country Link
US (2) US20210010045A1 (en)
EP (1) EP3650550A4 (en)
JP (2) JPWO2019009130A1 (en)
KR (1) KR102728398B1 (en)
CN (1) CN110914444A (en)
AU (1) AU2018295686B2 (en)
SG (1) SG11202000020RA (en)
TW (1) TWI784019B (en)
WO (1) WO2019009130A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6704083B1 (en) * 2019-11-22 2020-06-03 東邦チタニウム株式会社 Copper powder and its manufacturing method
EP4101301A1 (en) * 2021-06-08 2022-12-14 DMK Deutsches Milchkontor GmbH Method for the preparation of galactooligosaccharides

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6279791A (en) * 1985-10-02 1987-04-13 Snow Brand Milk Prod Co Ltd Production of 6'-galactosyl lactose utilizing lactose-assimilating microorganism
JPS63109789A (en) 1986-10-27 1988-05-14 Yakult Honsha Co Ltd Production of oligosaccharide
JPH03151875A (en) * 1989-11-10 1991-06-28 Yakult Honsha Co Ltd Stabilization of beta-galactosidase
JPH0522517A (en) 1991-07-09 1993-01-29 Fuji Xerox Co Ltd Contact type image sensor
DE4426846A1 (en) * 1994-07-28 1994-12-15 Suspa Compart Ag Length-adjustable gas spring for chairs, tables or the like
JP2001245690A (en) * 2000-03-03 2001-09-11 Yakult Honsha Co Ltd Method for producing glycoside or oligosaccharide
KR100945306B1 (en) * 2007-12-31 2010-03-03 주식회사 삼양제넥스 Manufacturing method of high purity galactooligosaccharide
JP5238373B2 (en) 2008-06-25 2013-07-17 株式会社ヤクルト本社 Mesenteric fat reducing agent
EP2620506A1 (en) * 2012-01-25 2013-07-31 Arla Foods Amba Method of producing a galacto-oligosaccharide-containing composition
CN105274166B (en) 2015-12-04 2018-09-11 南京林业大学 A kind of method of galactooligosaccharide coproduction Pfansteihl
CA2992497C (en) * 2016-01-12 2020-12-22 Vitalus Nutrition Inc. Method for producing galactooligosaccharides from lactose
RU2622078C1 (en) * 2016-01-12 2017-06-09 федеральное государственное автономное образовательное учреждение высшего образования "Северо-Кавказский федеральный университет" Method for combined enzyme beta-galactosidase production

Also Published As

Publication number Publication date
US20210010045A1 (en) 2021-01-14
EP3650550A4 (en) 2021-04-07
US11718841B2 (en) 2023-08-08
TWI784019B (en) 2022-11-21
AU2018295686A1 (en) 2020-02-06
US20220112533A1 (en) 2022-04-14
CN110914444A (en) 2020-03-24
JPWO2019009130A1 (en) 2020-05-07
JP2023093593A (en) 2023-07-04
KR20200026274A (en) 2020-03-10
EP3650550A1 (en) 2020-05-13
AU2018295686B2 (en) 2023-12-21
WO2019009130A1 (en) 2019-01-10
JP7535620B2 (en) 2024-08-16
SG11202000020RA (en) 2020-02-27
KR102728398B1 (en) 2024-11-11

Similar Documents

Publication Publication Date Title
JP6105680B2 (en) Method for producing ultra high purity galactooligosaccharide
Adamczak et al. Influence of reaction medium composition on enzymatic synthesis of galactooligosaccharides and lactulose from lactose concentrates prepared from whey permeate
JP6183921B2 (en) Method for producing galactooligosaccharide-containing composition
Jayamuthunagai et al. D-Tagatose production by permeabilized and immobilized Lactobacillus plantarum using whey permeate
CN103080329B (en) Compositions containing galacto-oligosaccharide and production method thereof
Silvério et al. Biocatalytic approaches using lactulose: end product compared with substrate
Yu et al. Immobilization of whole cells of Lactococcus lactis containing high levels of a hyperthermostable β-galactosidase enzyme in chitosan beads for efficient galacto-oligosaccharide production
JP7535620B2 (en) Method for producing galactooligosaccharides
Pocedičová et al. Preparation of galacto-oligosaccharides using membrane reactor
Saburi et al. Practical preparation of epilactose produced with cellobiose 2-epimerase from Ruminococcus albus NE1
CN101341255A (en) Method for producing oligosaccharides
JPS6391092A (en) Production of oligosaccharide
Guerrero et al. Lactulose
KR20140012932A (en) Method for preparing galactooligosaccharide using lactobacillus extract and whey
WO2024043297A1 (en) Composition production method, oligosaccharide-containing composition obtained thereby, and utilization of said method and composition
Jung et al. Production and application of galacto-oligosaccharides from lactose by a recombinant β-galactosidase of Bifidobacterium infantis overproduced by Pichia pastoris
JP2000041693A (en) Method for producing galactooligosaccharide
Iliev et al. Study of the transgalactosylation activity of β-galactosidase from a new strain Kluyveromyces lactis 3
JP2017018135A (en) Galactooligosaccharide-containing composition and method for producing the same
CN121099912A (en) Spray-dried milk or milk-based powder compositions and methods thereof
KUMAR STUDY ON OLIGOSACCHARIDE FORMATION BY β-GALACTOSIDASE OF LACTIC ACID BACTERIA
KR20150040842A (en) Method for Preparing Galactooligosaccharide Using Lactobacillus Extract and Whey
KR20130083174A (en) Methods for preparing galactooligosaccharide using lactobacillus extract and whey
JPH09238696A (en) Method for producing sugar composition containing 3&#39;galacto-oligosaccharide